Publication | Closed Access
Long-term survival of kidney allografts.
30
Citations
0
References
1987
Year
Transplantation MedicineImmunologySurgeryGraft Loss RatesCadaver DonorsImmunotherapyHematologyGraft SurvivalTransplantationKidney TransplantBlood TransplantationTransplant ImmunologyTransplant RejectionCsa EraUrologyKidney AllograftsKidney TransplantationMedicineNephrologyGraft Rejection
1. Late graft loss rates did not improve substantially in patients with functioning grafts one or 5 years posttransplant when compared with all patients in pre-CsA kidney transplants. Graft loss rates were the same for recipients of first and regraft transplants involving cadaver donors after the first year posttransplant. 2. Long-term graft survival rates have not improved over the years to any great degree, in contrast to one-year rates. 3. The long-term patient survival rates have improved dramatically over the years for both cadaver and living donor transplants. 4. In recent transplants, zero HLA-A,B mismatched grafts appear to have an advantage in terms of long-term graft survival both with and without CsA immunosuppression. Matching for HLA-DR alone did not influence long-term graft survival rates. 5. In cadaver donor grafts, those with zero mismatches for HLA-B,DR or HLA-A,B,DR antigens had the highest long-term graft survival rates, particularly with transplants involving CsA. 6. From these long-term projections, it would seem that histocompatibility continues to exert a major influence on transplants in the CsA era. Only living-related donor or well-matched cadaver donor transplants appear likely to have high long-term graft survival rates.